SEC 13F Intelligence

Finemark National Bank & Trust / ELV

Finemark National Bank & Trust’s Elevance Health Inc Formerly Position

Does Finemark National Bank & Trust own Elevance Health Inc Formerly (ELV)? Yes — 44.1K shares worth $15M (+0.48% of its 13F portfolio) as of Q4 2025, down from 45.2K shares the prior filed quarter.

Position Value
$15M
Q4 2025
Shares
44.1K
% of Portfolio
+0.48%
Quarters Held
29
currently held

Position History ELV

Reported value by quarter
Q4 ’18: $7MQ4 ’18Q1 ’19: $8MQ2 ’19: $8MQ3 ’19: $7MQ4 ’19: $9MQ4 ’19Q1 ’20: $7MQ2 ’20: $9MQ3 ’20: $9MQ4 ’20: $10MQ4 ’20Q1 ’21: $12MQ2 ’21: $13MQ3 ’21: $13MQ4 ’21: $16MQ4 ’21Q1 ’22: $17MQ2 ’22: $16MQ3 ’22: $15MQ4 ’22: $17MQ4 ’22Q1 ’23: $15MQ2 ’23: $15MQ3 ’23: $14MQ4 ’23: $15MQ4 ’23Q1 ’24: $17MQ2 ’24: $18MQ3 ’24: $17MQ4 ’24: $12MQ4 ’24Q1 ’25: $14MQ2 ’25: $18MQ3 ’25: $15MQ4 ’25: $15MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202544.1K$15M+0.48%
Q3 202545.2K$15M+0.48%
Q2 202547.3K$18M+0.63%
Q1 202532.6K$14M+0.52%
Q4 202432.2K$12M+0.41%
Q3 202432.8K$17M+0.59%
Q2 202433.0K$18M+0.66%
Q1 202432.6K$17M+0.63%
Q4 202332.1K$15M+0.62%
Q3 202332.3K$14M+0.61%
Q2 202332.9K$15M+0.60%
Q1 202333.2K$15M+0.65%
Q4 202233.2K$17M+0.77%
Q3 202233.1K$15M+0.72%
Q2 202234.0K$16M+0.73%
Q1 202233.8K$17M+0.66%
Q4 202134.0K$16M+0.60%
Q3 202133.8K$13M+0.53%
Q2 202133.6K$13M+0.52%
Q1 202133.2K$12M+0.50%
Q4 202031.8K$10M+0.46%
Q3 202033.1K$9M+0.43%
Q2 202032.8K$9M+0.48%
Q1 202032.9K$7M+0.47%
Q4 201930.8K$9M+0.46%
Q3 201929.6K$7M+0.38%
Q2 201929.5K$8M+0.46%
Q1 201927.7K$8M+0.46%
Q4 201827.2K$7M+0.48%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Finemark National Bank & Trust’s full portfolio or all institutional holders of ELV.